Clinical Trials Browser

Phase 2 × Immune Checkpoint Inhibitors × Lymphoid × Clear all

NCT07385989 2026-02-04

Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Extranodal NK-T-Cell

NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Phase 2 Not yet recruiting

Lymphoma, B-Cell

NCT05871684 2023-08-01

A Combination Study of CAR-T Therapy in r/r B-NHL

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05137886 2021-12-17

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Phase 2 Unknown

Hodgkin Disease, Recurrence

NCT04539444 2021-08-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence